Nick Lynton's departure as Chief Legal and Privacy Officer of Cardlytics, Inc. was reported; the filing names no successor. As of November 6, 2026, Cardlytics, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on May 12, 2026, naming 1 departure (Form 8-K, May 12, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Cardlytics, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Cardlytics, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-05-12. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Cardlytics, Inc. files it.
Layoffs on record: about 90 jobs, latest 2025-10-02 (layoff filings and notices).
Also on the record for Cardlytics, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 20, 2025 | Stake report, Schedule 13D/A, by CAS Investment Partners, LLC | 9.8% of the class | 5%+ stakes | Source |
| July 29, 2025 | Stake report, Schedule 13G/A, by The Vanguard Group | 4.6% of the class | 5%+ stakes | Source |
| July 16, 2025 | Stake report, Schedule 13G/A, by BlackRock, Inc. | 2.1% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Cardlytics, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Cardlytics, Inc. and the records around it.
Cardlytics, Inc. elsewhere on the record
- Layoff notices Oct 2025
- 5%+ stake filings Aug 2025
- Who owns it
Companies that share a holder
- CAS Investment Partners, LLC also filed stake reports on 1 other company: Hilton Grand Vacations Inc. (Aug 2026)
- BlackRock, Inc. also filed stake reports on 1596 other companies: AvePoint, Inc. (Nov 2026), BIOMARIN PHARMACEUTICAL INC (Nov 2026), MSG RANGERS CORP (Nov 2026)
- The Vanguard Group also filed stake reports on 2384 other companies: BellRing Brands, Inc. (Sep 2026), CAL-MAINE FOODS INC (Sep 2026), FTAI Aviation Ltd. (Sep 2026)
Watch Cardlytics, Inc.
Get an email when Cardlytics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Cardlytics, Inc.?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Cardlytics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Cardlytics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
5 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-05-12 | Out | Chief Legal and Privacy Officer | 8-K, 2026-05-12 |
Who leads Cardlytics, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- Chief Legal and Privacy Officer: Nick Lynton, departure reported (filed 2026-05-12). No successor is named in these filings.
New leaders reset buying decisions — get the Full Report on Cardlytics, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the Chief Legal and Privacy Officer at Cardlytics, Inc., with the record behind each one.
Find candidates like Chief Legal and Privacy Officer at Cardlytics, Inc.Every change, in the filing's words
Departing: Nick Lynton, Chief Legal and Privacy Officer
On May 10, 2026, Nick Lynton, Chief Legal and Privacy Officer of Cardlytics, Inc. (the "Company"), notified the Company of his intent to resign from such position, effective as of the earlier of the appointment of his successor or the close of business on July 3, 2026 (the "Effective Date").
- In connection with Mr. Lynton's resignation, on May 10, 2026, the Company and Mr. Lynton entered into a Transition Agreement (the "Transition Agreement"), which replaced the Amended and Restated Separation Pay Agreement between Mr. Lynton and the Company, dated as of August 8, 2022.
- Pursuant to the Transition Agreement, Mr. Lynton will continue to provide services to the Company through the Effective Date.
- In the event Mr. Lynton's successor is appointed prior to the Effective Date, Mr. Lynton will remain employed in a non-officer advisory role through the Effective Date, primarily focused on transitioning his responsibilities.
- Through the date his employment ends, Mr. Lynton will continue to receive his current base salary and benefits.
- The Transition Agreement further states that following the Effective Date, and provided that Mr. Lynton complies with the Transition Agreement and further executes a separate Release Agreement that contains both a release of claims against the Company and certain restrictive covenants that are binding upon Mr. Lynton, the Company shall pay Mr. Lynton a lump sum separation payment of $380,000 and shall reimburse Mr. Lynton on a monthly basis for the COBRA premiums actually paid by Mr. Lynton for up to twelve months, subject to certain criteria.
Tools for this story
Each opens in a new tab, filled in for Cardlytics, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.